The Clorox Company (NYSE:CLX) Receives $113.07 Consensus Price Target from Analysts

Shares of The Clorox Company (NYSE:CLX) have received an average recommendation of “Reduce” from the seventeen analysts that are covering the company, MarketBeat Ratings reports. Four research analysts have rated the stock with a sell rating, twelve have issued a hold rating and one has issued a buy rating on the company. The average 12 month price target among analysts that have issued ratings on the stock in the last year is $111.3333.

A number of research firms recently commented on CLX. Rothschild & Co Redburn set a $117.00 price objective on Clorox in a research report on Friday, February 13th. UBS Group reduced their price objective on Clorox from $121.00 to $110.00 and set a “neutral” rating for the company in a research report on Tuesday, April 7th. BNP Paribas Exane upgraded Clorox from an “underperform” rating to a “neutral” rating in a research report on Wednesday, February 11th. JPMorgan Chase & Co. reiterated an “underweight” rating and set a $99.00 price objective (down from $117.00) on shares of Clorox in a research report on Friday, April 17th. Finally, Deutsche Bank Aktiengesellschaft reduced their price objective on Clorox from $101.00 to $100.00 and set a “hold” rating for the company in a research report on Monday, April 20th.

Clorox Trading Up 1.0%

Clorox stock opened at $98.68 on Wednesday. The company has a current ratio of 0.74, a quick ratio of 0.48 and a debt-to-equity ratio of 71.03. The business’s fifty day simple moving average is $110.40 and its two-hundred day simple moving average is $109.48. Clorox has a 12 month low of $96.58 and a 12 month high of $143.96. The company has a market capitalization of $11.93 billion, a price-to-earnings ratio of 16.12, a price-to-earnings-growth ratio of 0.48 and a beta of 0.65.

Clorox (NYSE:CLX) last announced its quarterly earnings results on Tuesday, February 3rd. The company reported $1.39 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.43 by ($0.04). The business had revenue of $1.67 billion for the quarter, compared to the consensus estimate of $1.64 billion. Clorox had a net margin of 11.17% and a return on equity of 383.01%. The company’s revenue for the quarter was down .8% compared to the same quarter last year. During the same period in the previous year, the company earned $1.55 earnings per share. As a group, equities analysts predict that Clorox will post 5.87 earnings per share for the current fiscal year.

Clorox Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, May 8th. Shareholders of record on Wednesday, April 22nd will be given a $1.24 dividend. The ex-dividend date is Wednesday, April 22nd. This represents a $4.96 dividend on an annualized basis and a yield of 5.0%. Clorox’s dividend payout ratio is presently 81.05%.

Institutional Trading of Clorox

Several institutional investors have recently made changes to their positions in the business. Haverford Trust Co raised its stake in shares of Clorox by 2.8% in the 4th quarter. Haverford Trust Co now owns 3,070 shares of the company’s stock valued at $310,000 after purchasing an additional 84 shares in the last quarter. Field & Main Bank raised its stake in shares of Clorox by 3.3% in the 4th quarter. Field & Main Bank now owns 3,100 shares of the company’s stock valued at $313,000 after purchasing an additional 100 shares in the last quarter. Golden State Wealth Management LLC raised its stake in shares of Clorox by 28.2% in the 4th quarter. Golden State Wealth Management LLC now owns 454 shares of the company’s stock valued at $46,000 after purchasing an additional 100 shares in the last quarter. Fisher Asset Management LLC raised its stake in shares of Clorox by 1.7% in the 3rd quarter. Fisher Asset Management LLC now owns 6,053 shares of the company’s stock valued at $746,000 after purchasing an additional 102 shares in the last quarter. Finally, Blue Trust Inc. raised its stake in shares of Clorox by 8.5% in the 3rd quarter. Blue Trust Inc. now owns 1,333 shares of the company’s stock valued at $164,000 after purchasing an additional 104 shares in the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.